Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

Emilie Cornec-Le Gall, Jaime D. Blais, Maria V. Irazabal, Olivier Devuyst, Ron T. Gansevoort, Ron D. Perrone, Arlene B. Chapman, Frank S. Czerwiec, John Ouyang, Christina M. Heyer, Sarah R. Senum, Yannick Le Meur, Vicente E. Torres, Peter C. Harris

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial'. Together they form a unique fingerprint.

Medicine & Life Sciences